Standard Chemical & Pharmaceutical Co (TPE:1720) Change In Receivables : NT$-154 Mil (TTM As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Standard Chemical & Pharmaceutical Co Change In Receivables?

Standard Chemical & Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2024 was NT$-106 Mil. It means Standard Chemical & Pharmaceutical Co's Accounts Receivable increased by NT$106 Mil from Sep. 2023 to Mar. 2024 .

Standard Chemical & Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2022 was NT$-44 Mil. It means Standard Chemical & Pharmaceutical Co's Accounts Receivable increased by NT$44 Mil from Dec. 2021 to Dec. 2022 .

Standard Chemical & Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was NT$1,056 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Standard Chemical & Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 59.70.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Standard Chemical & Pharmaceutical Co's liquidation value for the three months ended in Mar. 2024 was NT$243 Mil.

Standard Chemical & Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Standard Chemical & Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard Chemical & Pharmaceutical Co Change In Receivables Chart

Standard Chemical & Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-3.35

26.02

-50.43

-268.79

-44.42

Standard Chemical & Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-65.72	85.02	11.70	-60.39	-105.76

Standard Chemical & Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-154 Mil.

Standard Chemical & Pharmaceutical Co (TPE:1720) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Standard Chemical & Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1055.728	/	1613.535	*	91
=	59.70

2. In Ben Graham's calculation of liquidation value, Standard Chemical & Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Standard Chemical & Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2138.752	-	3523.836	+	0.75 * 1055.728	+	0.5 * 1673.348
=	243

Standard Chemical & Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Standard Chemical & Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Standard Chemical & Pharmaceutical Co (TPE:1720) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Standard Chemical & Pharmaceutical Co Ltd (TPE:1720) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 154, Kaiyuan Road, Xinying District, Tainan, TWN, 73055

Website

https://www.standard.com.tw

Standard Chemical & Pharmaceutical Co Ltd is a pharmaceutical company. Along with its subsidiaries, the firm is engaged in the pharmaceutical development, manufacturing, and sales of Active Pharmaceuticals Ingredients (API), health supplements, medical equipment, neoangelac plus milk powder, and adult supplements. It offers pharmaceutical products in healthcare segments including the circulatory system, digestive system, metabolism, anti-microbial, membrane drugs, and respiratory system. The company generates a majority of its revenue from Taiwan.

Standard Chemical & Pharmaceutical Co (TPE:1720) Headlines

No Headlines